摘要
低循环高密度脂蛋白 (HDL) 不仅是代谢综合征的定义标准,而且更普遍地与动脉粥样硬化心血管疾病 (ASCVD) 和其他慢性疾病有关。氧化应激是心脏代谢疾病的标志,通过抑制其功能进一步影响 HDL 活性。尤其是白细胞衍生酶髓过氧化物酶 (MPO) 最近引起了极大的兴趣,因为它催化氧化活性物质的形成,从而改变 HDL 的结构和功能,最终增加心血管风险。相反,对氧磷酶-1 (PON1) 是一种 HDL 相关酶,可保护 HDL 免受脂质氧化,然后作为预防 ASCVD 的保护因子。值得注意的是,最近的研究已经证明 MPO、PON1 和 HDL 如何形成功能复合物,其中 PON1 部分抑制 MPO 活性,而 MPO 反过来部分灭活 PON1。与此一致,高 MPO/PON1 比率是 ASCVD 患者的特征和代谢综合征,并已被建议作为功能失调的 HDL 的潜在标志物以及 ASCVD 的预测因子。在这篇综述中,我们总结了 MPO 和 PON1 在结构、功能和与 HDL 活性相互作用方面相互作用的证据。我们还提供了体外和实验动物模型的概述,最后侧重于来自一组 ASCVD 和代谢综合征患者的临床证据。
关键词: 高密度脂蛋白、髓过氧化物酶、对氧磷酶、动脉粥样硬化、代谢综合征、HDL 活性。
[http://dx.doi.org/10.1146/annurev.med.54.101601.152409] [PMID: 12414916]
[http://dx.doi.org/10.1016/0021-9150(91)90109-G] [PMID: 1684707]
[http://dx.doi.org/10.1093/eurheartj/ehz455] [PMID: 31504418]
[http://dx.doi.org/10.1371/journal.pone.0144372] [PMID: 26680360]
[http://dx.doi.org/10.1016/j.freeradbiomed.2006.07.006] [PMID: 16962927]
[http://dx.doi.org/10.1002/biof.1202] [PMID: 25809447]
[http://dx.doi.org/10.3389/fphar.2015.00222] [PMID: 26528181]
[http://dx.doi.org/10.1002/biof.16] [PMID: 19319852]
[http://dx.doi.org/10.1016/0014-5793(91)80962-3] [PMID: 1650712]
[http://dx.doi.org/10.1172/JCI1649] [PMID: 9541487]
[http://dx.doi.org/10.1172/JCI118359] [PMID: 8675659]
[http://dx.doi.org/10.1172/JCI42946] [PMID: 21701070]
[http://dx.doi.org/10.1371/journal.pone.0173385] [PMID: 28278274]
[http://dx.doi.org/10.1194/jlr.M400511-JLR200] [PMID: 15772423]
[http://dx.doi.org/10.1016/j.plipres.2015.08.003] [PMID: 26416579]
[http://dx.doi.org/10.1210/jc.2003-031897] [PMID: 15181084]
[http://dx.doi.org/10.1210/jc.2004-0486] [PMID: 15613429]
[http://dx.doi.org/10.1161/01.CIR.101.21.2510] [PMID: 10831526]
[http://dx.doi.org/10.2174/1874091X01206010078] [PMID: 22888373]
[http://dx.doi.org/10.1016/j.atherosclerosis.2005.08.008] [PMID: 16157342]
[http://dx.doi.org/10.1016/S0014-5793(99)00677-8] [PMID: 10386609]
[http://dx.doi.org/10.1172/JCI200421109] [PMID: 15314690]
[http://dx.doi.org/10.1194/jlr.M004085] [PMID: 20064972]
[http://dx.doi.org/10.1074/jbc.M109.047605] [PMID: 19726691]
[http://dx.doi.org/10.1161/CIRCULATIONAHA.108.836346] [PMID: 20026785]
[http://dx.doi.org/10.1093/cvr/cvn051] [PMID: 18296711]
[http://dx.doi.org/10.1074/jbc.M406762200] [PMID: 15292228]
[http://dx.doi.org/10.1073/pnas.0802025105] [PMID: 18719109]
[http://dx.doi.org/10.1016/S0891-5849(00)00204-5] [PMID: 11020661]
[http://dx.doi.org/10.1074/jbc.M411484200] [PMID: 15574409]
[http://dx.doi.org/10.1074/jbc.C600011200] [PMID: 16497665]
[http://dx.doi.org/10.1016/j.bbalip.2011.11.011] [PMID: 22178192]
[http://dx.doi.org/10.1172/JCI67478] [PMID: 23908111]
[http://dx.doi.org/10.1074/jbc.272.47.29711] [PMID: 9368040]
[http://dx.doi.org/10.1042/bj3270487] [PMID: 9359420]
[http://dx.doi.org/10.1089/ars.2010.3640] [PMID: 21235354]
[http://dx.doi.org/10.1038/nm1637] [PMID: 17828273]
[http://dx.doi.org/10.1021/bi050862i] [PMID: 16128586]
[http://dx.doi.org/10.1016/j.atherosclerosis.2014.03.009] [PMID: 24704632]
[http://dx.doi.org/10.1016/j.bbrc.2010.11.053] [PMID: 21094143]
[http://dx.doi.org/10.1155/2015/592594] [PMID: 26257958]
[http://dx.doi.org/10.1016/j.cca.2014.12.014] [PMID: 25528002]
[http://dx.doi.org/10.1001/jama.286.17.2136] [PMID: 11694155]
[http://dx.doi.org/10.1073/pnas.0405292101] [PMID: 15326314]
[http://dx.doi.org/10.1089/ars.2011.4403] [PMID: 22462773]
[http://dx.doi.org/10.1016/j.numecd.2008.12.005] [PMID: 19201174]
[PMID: 23852840]
[http://dx.doi.org/10.1016/j.atherosclerosis.2013.08.037] [PMID: 24267244]
[http://dx.doi.org/10.1016/j.clinbiochem.2016.03.011] [PMID: 27129797]
[http://dx.doi.org/10.1024/0301-1526/a000643] [PMID: 28602123]
[http://dx.doi.org/10.1016/j.atherosclerosis.2018.11.004] [PMID: 30448568]
[http://dx.doi.org/10.1016/j.atherosclerosis.2017.06.007] [PMID: 28645072]
[http://dx.doi.org/10.1016/j.metabol.2019.06.004] [PMID: 31202834]
[http://dx.doi.org/10.1007/s00403-019-01976-z] [PMID: 31531730]
[http://dx.doi.org/10.3899/jrheum.141532] [PMID: 26233507]
[http://dx.doi.org/10.35440/hutfd.579011]
[http://dx.doi.org/10.1055/a-0577-7776] [PMID: 29529688]
[http://dx.doi.org/10.4093/dmj.2015.39.1.59] [PMID: 25729714]
[http://dx.doi.org/10.1042/CS20130369] [PMID: 23905837]
[http://dx.doi.org/10.1586/erc.11.182] [PMID: 22390807]
[http://dx.doi.org/10.1515/CCLM.2005.104] [PMID: 16006255]
[http://dx.doi.org/10.1016/j.cca.2006.01.011] [PMID: 16500635]
[http://dx.doi.org/10.1155/2015/761939] [PMID: 26451069]
[http://dx.doi.org/10.1242/dmm.009209] [PMID: 22822045]
[http://dx.doi.org/10.1016/j.cca.2011.06.010] [PMID: 21693110]
[http://dx.doi.org/10.2337/db14-1273] [PMID: 25414015]
[http://dx.doi.org/10.1016/j.clinbiochem.2012.01.008] [PMID: 22285381]
[http://dx.doi.org/10.1016/j.amjcard.2011.10.008] [PMID: 22105786]
[http://dx.doi.org/10.2337/dc18-0049] [PMID: 30201848]